Orthopediatrics (NASDAQ:KIDS) Releases Earnings Results

Orthopediatrics (NASDAQ:KIDS) announced its earnings results on Thursday. The company reported ($0.18) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.17) by ($0.01), Briefing.com reports. Orthopediatrics had a negative return on equity of 12.92% and a negative net margin of 15.77%. The company had revenue of $20.74 million during the quarter, compared to the consensus estimate of $19.87 million. During the same period in the prior year, the firm posted ($0.15) earnings per share. The company’s revenue was up 31.1% on a year-over-year basis.

Shares of NASDAQ:KIDS traded up $1.58 during trading on Friday, hitting $37.50. 125,300 shares of the company’s stock were exchanged, compared to its average volume of 74,879. The firm has a 50-day moving average price of $36.29 and a two-hundred day moving average price of $36.98. The company has a current ratio of 2.53, a quick ratio of 1.75 and a debt-to-equity ratio of 0.24. The firm has a market cap of $560.98 million, a P/E ratio of -39.06 and a beta of 0.23. Orthopediatrics has a 1-year low of $25.11 and a 1-year high of $47.82.

A number of brokerages have weighed in on KIDS. Piper Jaffray Companies boosted their target price on shares of Orthopediatrics from $40.00 to $44.00 and gave the stock an “overweight” rating in a research note on Friday. Zacks Investment Research downgraded shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Saturday. BidaskClub downgraded shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Friday. Finally, ValuEngine cut shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $44.40.

About Orthopediatrics

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.

Read More: Consumer Price Index (CPI)

Earnings History for Orthopediatrics (NASDAQ:KIDS)

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.